Working to Eradicate Gynecologic Cancers

100
Distinct immune characteristics in women with deleterious germline BRCA1/2 mutations (gBRCAm)-associated high-grade serous ovarian cancer (HGSOC)

Sunday, March 29, 2015: 3:05 PM
Salon C-D (Hilton Chicago)
J. M. Lee, Y. Tomita, V. Chiou, S. Lee, M. Yu, N. Houston, M. J. Lee, E. C. Kohn and J. Trepel
National Cancer Institute, Bethesda, MD